Clinical significance of SNP (rs2596542) in histocompatibility complex class I-related gene A promoter region among hepatitis C virus related hepatocellular carcinoma cases

Pichardo-Bahena, 2002, Relation between hepatocarcinoma and hepatitis C virus infection, Rev Gastroenterol Mex, 67, S36 Aguilar-Olivos, 2013, New insights in the diagnosis, pathogenesis and treatment of hepatitis B-and C-related hepatocellular carcinoma, Curr Hepatitis Rep, 12, 297, 10.1007/s11901-013-0192-4 Klitz, 1992, Viruses, cancer and the MHC, Nature, 356, 17, 10.1038/356017a0 Bahram, 1994, A second lineage of mammalian major histocompatibility complex class I genes, Proc Natl Acad Sci, 91, 6259, 10.1073/pnas.91.14.6259 Groh, 1996, Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium, Proc Natl Acad Sci, 93, 12445, 10.1073/pnas.93.22.12445 Das, 2001, MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function, Immunity, 15, 83, 10.1016/S1074-7613(01)00168-6 Salih, 2006, Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients, Hum Immunol, 67, 188, 10.1016/j.humimm.2006.02.008 Fodil, 1996, Allelic repertoire of the human MHC class IMICA gene, Immunogenetics, 44, 351, 10.1007/BF02602779 Bauer, 1999, Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA, Science, 285, 727, 10.1126/science.285.5428.727 Salih, 2003, Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia, Blood, 102, 1389, 10.1182/blood-2003-01-0019 Salih, 2002, Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding, J Immunol, 169, 4098, 10.4049/jimmunol.169.8.4098 Groh, 2002, Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation, Nature, 419, 734, 10.1038/nature01112 Kumar, 2011, Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma, Nat Genet, 43, 455, 10.1038/ng.809 Tong, 2013, Hepatitis B virus-induced hepatocellular carcinoma: functional roles of MICA variants, J Viral Hepatitis, 20, 687, 10.1111/jvh.12089 Groh, 2001, Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells, Nat Immunol, 2, 255, 10.1038/85321 Waldhauer, 2008, Tumor-associated MICA is shed by ADAM proteases, Cancer Res, 68, 6368, 10.1158/0008-5472.CAN-07-6768 Doubrovina, 2003, Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma, J Immunol, 171, 6891, 10.4049/jimmunol.171.12.6891 Groh, 1999, Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB, Proc Natl Acad Sci, 96, 6879, 10.1073/pnas.96.12.6879 Kohga, 2008, Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma, Cancer Sci, 99, 1643, 10.1111/j.1349-7006.2008.00859.x Li, 2009, Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis, Cancer Immunol Immunother, 58, 641, 10.1007/s00262-008-0585-3 Liu, 2009, MicroRNA-18a prevents estrogen receptor-α expression, promoting proliferation of hepatocellular carcinoma cells, Gastroenterology, 136, 683, 10.1053/j.gastro.2008.10.029 Ratziu, 2002, Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis, Hepatology, 35, 1485, 10.1053/jhep.2002.33324 Hanafy, 2016, Association of thrombogenic genes polymorphisms with hepatocellular carcinoma in HCV Egyptian patients, Gene, 580, 37, 10.1016/j.gene.2016.01.002 Ripoll, 2009, Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis, J Hepatol, 50, 923, 10.1016/j.jhep.2009.01.014 Spinella, 2016, Albumin in chronic liver disease: structure, functions and therapeutic implications, Hepatol Int, 10, 124, 10.1007/s12072-015-9665-6 Al-Qahtani, 2013, Genetic variation at − 1878 (rs2596542) in MICA gene region is associated with chronic hepatitis B virus infection in Saudi Arabian patients, Exp Mol Pathol, 95, 255, 10.1016/j.yexmp.2013.08.005 Lange, 2013, Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma, J Hepatol, 59, 504, 10.1016/j.jhep.2013.04.032 Lo, 2013, Identification of a functional variant in the MICA promoter which regulates MICA expression and increases HCV-related hepatocellular carcinoma risk, PloS One, 8, e61279, 10.1371/journal.pone.0061279 Holdenrieder, 2006, Soluble MICA in malignant diseases, Int J Cancer, 118, 684, 10.1002/ijc.21382 Matsuda, 2012, MICA variation and soluble MICA are possible prognostic biomarkers for HBV-induced hepatocellular carcinoma, Cancer Res, 72, 1648, 10.1158/1538-7445.AM2012-1648 Motomura, 2012, Neither MICA nor DEPDC5 genetic polymorphisms correlate with hepatocellular carcinoma recurrence following hepatectomy, HPB Surgery, 24, 947 Hoshida, 2012, Genomic risk of hepatitis C-related hepatocellular carcinoma, J Hepatol, 56, 729, 10.1016/j.jhep.2011.08.015 Chen, 2013, Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci in a Chinese population, PloS One, 8, e77315, 10.1371/journal.pone.0077315 Kumar, 2012, Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma, PloS One, 7, e44743, 10.1371/journal.pone.0044743 Jiang, 2015, Genetic variations in STAT4, C2, HLA-DRB1 and HLA-DQ associated with risk of hepatitis B virus-related liver cirrhosis, Sci Rep, 5, 10.1038/srep16278 Li, 2016, Interaction between polymorphisms of IFN-γ and MICA correlated with hepatocellular carcinoma, Med Sci Monit, 22, 549, 10.12659/MSM.895101 Li, 2013, Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma, Chin J Cancer, 32, 141, 10.5732/cjc.012.10025 Xu, 2011, Major histocompatibility complexclass-1 related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer; uric acid accumulation in gemcitabine-induced (MICA/B) expression, BMC Cancer, 11, 194, 10.1186/1471-2407-11-194